PLATINUM-SENSITIVE OVARIAN CARCINOMA
Clinical trials for PLATINUM-SENSITIVE OVARIAN CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PLATINUM-SENSITIVE OVARIAN CARCINOMA trials appear
Sign up with your email to follow new studies for PLATINUM-SENSITIVE OVARIAN CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test powerful new Immune-Boosting cocktail against tough ovarian cancers
Disease control Recruiting nowThis study is testing whether adding a new immune-stimulating drug (CDX-1140) to two existing cancer drugs works better for women whose ovarian cancer has returned. The goal is to see if this three-drug combination can shrink tumors more effectively, help patients live longer, an…
Matched conditions: PLATINUM-SENSITIVE OVARIAN CARCINOMA
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New trial tests if switching PARP inhibitors can help control advanced cancers
Disease control Recruiting nowThis study is testing whether the drug talazoparib can help control advanced cancers in patients whose tumors have specific mutations in genes that help repair DNA damage. It is enrolling 36 adults with various advanced solid tumors (like breast, ovarian, prostate, pancreatic, an…
Matched conditions: PLATINUM-SENSITIVE OVARIAN CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC